Microsoft, Telefonica announce new AI and edge computing partnership
Category: #tech  By Mateen Dalal  Date: 2019-02-26
  • share
  • Twitter
  • Facebook
  • LinkedIn

Microsoft, Telefonica announce new AI and edge computing partnership

Telefónica will expand the use of Microsoft’s Azure Cognitive Services over all customer relationship channels

The companies will also work to develop Telefónica’s smart applications for connected home devices

Microsoft Corp. and Telefónica recently announced a strategic partnership at the ongoing Mobile World Congress, for working together on projects to accelerate innovation at Telefónica and help transform the telecommunications industry.

Reportedly, the new partnership deal involves combining the power of Telefónica’s state-of-the-art networks and exceptional customer proposition with Microsoft’s Azure AI platform, for designing services that telcos will provide in the future. The agreement will also help evolve Microsoft’s edge computing strategy, which aims at positioning the company’s could division for the future, where a growing amount of application processing would be done closer to the end users.  

According to Telefónica, this partnership would build on the previous works of both the companies around the usage of data, as well as the Fourth Platform from Telefónica to power products such as its AI-powered digital assistant, Aura. The use of intelligent technology for transforming the network will remain a key focus of this partnership.

Telefónica, as part of the new agreement, would be expanding its use of Azure Cognitive Services across supplier and customer service channels, in addition to working with Microsoft to develop cloud-based connected home devices. The companies will particularly look to evaluate the use of Azure Cognitive Services as the basis for future smart applications of Telefónica, it informed.

Supposedly, Azure Cognitive Services enables users to benefit from the machine learning research of Microsoft for adding features like speech recognition into their applications. Telefónica already uses the service for Aura, its customer service chatbot.

Microsoft CEO Satya Nadella stated that, Telefónica has been leading in the use of AI to transform customer engagement, with this partnership helping to further build on this history of innovation. The companies will collaborate to apply the power of Azure and Azure AI in creating innovative experiences for millions of customers of Telefónica worldwide, Nadella added.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
By Mateen Dalal

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced that Bristo...

LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
By Mateen Dalal

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that it has acqu...

AbbVie buys Mavupharma to target STING pathway for cancer treatment
AbbVie buys Mavupharma to target STING pathway for cancer treatment
By Mateen Dalal

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the treatment o...